Home Tags Lonza

lonza

Lonza Reports Positive Start to 2018

Basel, Switzerland — Lonza reported a positive start, led by its contingent of healthcare businesses, during its quarterly earnings call. The former Capsugel business, now...

Lonza Opens Next Gen Cell-and-Gene-Therapy Manufacturing Facility

Pearland, TX – Lonza is opening the world’s largest dedicated cell-and-gene-therapy facility, built in anticipation of rising demand from developers of cell and gene...

Prolog Partners with Lonza to Invest in Wellness Startups

Basel, Switzerland - Swiss pharmaceutical and biotech firm Lonza is partnering with U.S.-based Prolog Ventures to create a venture capital fund focusing on consumer health...
Capsugel Lonza

Lonza’s Capsugel Integration on Track

Basel, Switzerland – Lonza’s integration of Capsugel is on track as the company forecasts combined high single-digit sales growth for the year. The first...

Lonza Reports Strong First Half Results

Basel, Switzerland – Lonza reported a strong growth path for the first half of 2017, with sales up 15.1% to CHF 2,323 million compared...

Lonza Closes Capsugel $5.5 Billion Purchase

Basel, Switzerland – Lonza announced today it has completed the acquisition of Capsugel S.A. from KKR for $5.5 billion in cash, including refinancing of...
mergers and acquisitions

Lonza Receives Approval to Buy Capsugel S.A.,

Basel, Switzerland, – Lonza today announced it has received all regulatory approvals for its proposed acquisition of Capsugel S.A., further establishing its position as...

Lonza Boasts Record First Quarter 2017

Basel, Switzerland — Lonza issued a press release boasting a record first quarter in 2017 in terms of sales and earnings, resulting from the...

Lonza and Sanofi Enter Strategic Partnership

Basel, Switzerland — Lonza and Sanofi have announced that they have plans to build and operate a large-scale mammalian cell culture facility for monoclonal...

Lonza to Acquire Capsugel

Updated 1/5/17 Basel, Switzerland — Lonza Group LLT formally announced the acquisition of Capsugel for $5.5 billion in cash, including refinancing Capsugel's existing debt of $2...

BACK ISSUES

MULTIMEDIA